L-Tryptophan in Mania
Archives of General PsychiatryPublished 1 January 1974
Arthur J. Prange
Citations275
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Five manic patients were treated with chlorpromazine hydrochloride, then with L-tryptophan, and five with LTP first, then CPZ, in a double-blind, placebo-controlled crossover study, finding LTP was slightly superior to CPZ in all regards.
Abstract
Five manic patients were treated with chlorpromazine hydrochloride (CPZ), then with L-tryptophan (LTP), and five with LTP first, then CPZ, in a double-blind, placebo-controlled crossover study. LTP was slightly superior to CPZ in all regards. Mania and depression may be linked by a central indoleamine deficit.
Keywords
Medicine
American Journal of PsychiatryTHE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCE
3,500 Citations1965Joseph J. Schildkraut
The British Journal of PsychiatryThe Biochemistry of Affective Disorders
1,224 Citations1967Alec Coppen
The weight of evidence suggests that biochemical changes are most important in the aetiology of affective disorders, and that psychological and environmental events may precipitate and maintain the biochemical events which in turn lead to the affective disorder.
Archives of General PsychiatryNorepinephrine in Depressive Reactions
1,149 Citations1965William E. Bunney
Rosenblatt et al, 9 in 1959, were among the first to specifically suggest that changes in brain norepinephrine (NEP) may be involved in depression, and hypothesized that the depressive state might be associated with a relative decrease of nore Alpinephrine.
The LancetA CHOLINERGIC-ADRENERGIC HYPOTHESIS OF MANIA AND DEPRESSION
1,101 Citations1972DavidS. Janowsky, JohnM. Davis +2 more
Considering manic-depressive disorders and related phenomena from the viewpoint of cholinergic-adrenergic balance, or conceptualising behaviour as having both adrenergic andcholinergic components, provides a framework for understanding the affective disorders.
ScienceBiogenic Amines and Emotion
873 Citations1967Joseph J. Schildkraut, Seymour S. Kety
Although there does appear to be a fairly consistent relationship between the effects of pharmacological agents on norepinephrine metabolism and on affective state, a rigorous extrapolation from pharmacological studies to pathophysiology cannot be made, and confirmation of this hypothesis must ultimately depend upon direct demonstration of the biochemical abnormality in the naturally occurring illness.
The LancetINTENSIFICATION OF THE CENTRAL SEROTONINERGIC PROCESSES AS A POSSIBLE DETERMINANT OF THE THYMOLEPTIC EFFECT
710 Citations1969I. P. Lapin, Gregory F. Oxenkrug
It is suggested that in depression the production of tryptophane pyrrolase by the liver is stimulated by raised blood-corticosteroid levels, and the metabolism of tryPTophane is shunted away from serotonin production, and towards kynurenine production.
Archives of General PsychiatryLithium As a Prophylactic Agent
574 Citations1967Poul Christian Baastrup
In order to demonstrate prophylactic drug action in a disorder such as manicdepressive psychosis, which is characterized by a capricious and largely unpredictable course, one must study a large number of patients who have a sufficiently high risk of relapse and who are observed for relapse.
The LancetPROPHYLACTIC LITHIUM IN AFFECTIVE DISORDERS
363 Citations1971Alec Coppen, R. Pérez Noguera +6 more
ScienceEffects of Amino Acid Feedings in Schizophrenic Patients Treated with Iproniazid
340 Citations1961William Pollin, Philippe V. Cardon +1 more
Large oral doses of individual amino acids were given three or four times daily for periods of 1 week to schizophrenic patients, some of whom were maintained on iproniazid.
Archives of General PsychiatryAbnormalities of Indoleamines in Affective Disorders
304 Citations1972Alec Coppen
Examining the concentration of 5HIAA in the lumbar CSF of patients suffering from affec¬ tive disorders found increasing evidence of an abnormality of indoleamines in the affective disorders, though the probenecid test showed evidence of decreased rate of 5-HT synthesis in these conditions.
The LancetTRYPTOPHAN IN THE TREATMENT OF DEPRESSION
274 Citations1967Alec Coppen, DavidM. Shaw +2 more
The patients given tryptophan and a monoamine-oxidase inhibitor tended to show a greater improvement than those treated by tryPTophan alone, and the addition of potassium and carbohydrate may also enhance the antidepressive activity of tryptophile and a Monoamine-Oxidase inhibitors.
NatureRegular Induction of Hypomania by L-Dopa in “Bipolar” Manic-depressive Patients
258 Citations1971Dennis L. Murphy, H. Keith H. Brodie +2 more
L-dopa was given to eighteen depressed patients, using the very large oral doses found to be effective in reversing many of the symptoms of Parkinson's disease10–17.
Journal of Pharmacology and Experimental TherapeuticsEFFECT OF PSYCHOTROPIC DRUGS ON TRYPTOPHAN CONCENTRATION IN THE RAT BRAIN
252 Citations1971Alessandro Tagliamonte, P. Tagliamonte +3 more
The administration of d -amphetamine, dibutyryl cyclic adenosine monophosphate and lithium or the exposure to hot environmental temperature, conditions known to increase brain serotonin synthesis, increased tryptophan concentration in brain by more than 100%.
A M A Archives of Neurology & PsychiatryCHLORPROMAZINE
248 Citations1954H. E. Lehmann
The purpose of this article is to report on the experiences with a new drug which seems to possess specific properties for the psychiatric management of excited states.
Archives of General PsychiatryThe Comparative Antidepressant Value of L-Tryptophan and Imipramine With and Without Attempted Potentiation by Liothyronine
248 Citations1972Alec Coppen
None of the treatments tested seemed to benefit any particular symptom of depression differenntially, and L-tryptophan had no specific effect on the sleep deficit of the syndrome.
Archives of General PsychiatryComparison of Lithium Carbonate and Chlorpromazine in the Treatment of Mania
244 Citations1972Robert F. Prien
Both drugs effectively reduced manic symptomatology but lithium carbonate left the patient feeling less sluggish and fatigued and chlorpromazine produced fewer severe side effects than Lithium carbonate, which appeared to be the better treatment.
Journal of Pharmacology and Experimental TherapeuticsEFFECT OF CHLORPROMAZINE ON ACCUMULATION AND DISAPPEARANCE OF CATECHOLAMINES FORMED FROM TYROSINE-C14 IN BRAIN
176 Citations1968Henrik Nybäck, Göran Sedvall
The results suggest that chlorpromazine accelerates synthesis and turnover of brain dopamine, possibly by blocking central dopamine receptors, in rats and mice.
Archives of General PsychiatryCerebral Monoamines and Depression
175 Citations1973H. M. van Praag
Findings lend support to the hypotheses which postulate a correlation between deficient central monoamine metabolism and the occurrence of depressive symptoms and justify the hypothesis that depressive syndromes similar in terms of psychopathological symptoms may nevertheless be based on disparate metabolic substrates.
ScienceShort- and Long-Term Lithium Administration: Effects on the Brain's Serotonergic Biosynthetic Systems
143 Citations1973Suzanne Knapp, Arnold J. Mandell
Conversion of tryptophan to serotonin in nerve endings becomes a joint function of the maintained increased uptake of tryaptophan and a decreased level of tryPTophan hydroxylase activity in nerve Ending by 10 days.
American Journal of PsychiatryDepression During Mania: Clinical Observations and Theoretical Implications
117 Citations1972Joel Kotin, Frederick K. Goodwin
The relationship of depression to mania in 20 hospitalized patients was systematically investigated through an analysis of nurses' and physicians' behavioral ratings and notes, and statistically significant positive associations between mania and depression were found in the majority of cases.
The British Journal of PsychiatryNormothymotics, “Mood-Normalizers”
113 Citations1963Mogens Schou
Normothymotics, “mood-normalizers”, is proposed as a collective name for drugs belonging to a group that is characterized by being active against affective disorders (manic-depressive psychosis), and evidence will be presented for the existence of this class of a group.
Archives of General PsychiatryEffect of L-Tryptophan on Brain Serotonin Metabolism in Depressed Patients
105 Citations1972David L. Dünner
Cerebrospinal fluid 5-HIAA, the major metabolite of serotonin, was assayed in a group of five depressed patients and the apparent increase in brain serotonin turnover produced by L-tryptophan in these patients was not accompanied by an improvement in depression.
Life SciencesNeuronally activated metabolism of brain serotonin: Effect of lithium
95 Citations1970M.H. Sheard, George K. Aghajanian
Pretreatment of rats with lithium chloride increased the rate of brain serotonin turnover and was accentuated by electrical stimulation of serotonincontaining neuronal perikarya in the dorsal raphe nucleus.
Archives of General PsychiatryDifferential Catechol-O-Methyltransferase Activity in Unipolar and Bipolar Affective Illness
90 Citations1971David L. Dünner
Red blood cell COMT activity was stable in patients and in control subjects up to eight months and the level of activity was not related to age, hospitalization, the presence of depressive symptomatology, or medication.
American Journal of PsychiatryToward a Biology of Depression: Some Suggestions from Neurophysiology
86 Citations1969Peter C. Whybrow, J. Mendels
This review of recent research suggests the existence of an unstable state of central nervous system hyperexcitability in depression, and possibly in mania, with an associated but disorganized intrinsic hyperactivity.
American Journal of PsychiatryThe Desire for Sexual Transformation: A Psychiatric Evaluation of Transsexualism
73 Citations1969Charles W. Socarides
In this author's view, an individual's wish for sexual transformation (transsexualism) does not constitute an independent diagnostic category and is a consequence of the inability to develop appropriate gender identity in accordance with anatomy.
Journal of Psychiatric ResearchThyroid-imipramine clinical and chemical interaction: Evidence for a receptor deficit in depression
65 Citations1972Arthur J. Prange, Ian C. Wilson +6 more
It is suggested that in some depressed patients there may exist a deficit in aminergic receptor sensitivity, which appears to be compensated in the periphery but not in the brain, and an induced increment as produced by adjunctive hormone treatment may contribute to recovery.
The British Journal of PsychiatryManic-Depressive Psychosis: An Alternative Conceptual Model
62 Citations1968J. H. Court
Psychosomatic MedicineIndoleamines and Affective Disorders
58 Citations1969Alexander H. Glassman
Evidence linking indoleamines and depressive disorders is reviewed and recently, evidence has been presented that the pharmacologic action of morphine is dependent on the metabolic turn‐over rate of an indoleamine.
Life SciencesEffect of L-DOPA treatment on brain serotonin metabolism in depressed patients
54 Citations1971Frederick K. Goodwin, David L. Dünner +1 more
The decreased accumulation of the acid metabolite of serotonin in the CSF following the blockade of its exit out of the CNS by probenecid is suggestive evidence that L-DOPA can decrease brain serotonin turnover in patients.
The LancetMETHYSERGIDE IN MANIA
34 Citations1969Alec Coppen, ArthurJ Prange +3 more
Analysis of variance showed that the drug was significantly less effective than placebo for talk and behavioural disturbance, and there was no evidence that methysergide was any better than placebo in the treatment of mania.
NeurologyRapid deterioration in patients with parkinsonism following tryptophan‐pyridoxine administration
33 Citations1972Colin D. Hall, Edward A. Weiss +2 more
It has been demonstrated that in parkinsonism the levels in the brain of the monoamine 5-hydroxytryptamine and the Levels in the cerebrospinal fluid of its metabolites are also significantly reduced, though to a lesser extent than those of d ~ p a r n i n e .
The British Journal of PsychiatrySyndromes of Psychosis
10 Citations1965John M. Hoenig
Franidy, I do not understand Dr. Kreitman's objections to my question “¿ schemaor diagnostician― (apart from its obviously deliberate over simplification) since he hirnSelICa11S for a clarification of causes of disagreement between clinicians.
